JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Rentokil Initial (LON:RTO) in a research report sent to investors on Wednesday. The brokerage currently has a GBX 345 ($4.51) price objective on the stock, up from their previous price objective of GBX 211 ($2.76).
RTO has been the topic of several other research reports. Peel Hunt reaffirmed an add rating on shares of Rentokil Initial in a report on Tuesday, July 31st. Deutsche Bank increased their price objective on shares of Rentokil Initial from GBX 320 ($4.18) to GBX 325 ($4.25) and gave the stock a hold rating in a report on Friday, August 17th. Jefferies Financial Group reissued a hold rating on shares of Rentokil Initial in a report on Monday, August 6th. Numis Securities reissued a hold rating and set a GBX 330 ($4.31) price objective on shares of Rentokil Initial in a report on Wednesday, August 1st. Finally, Citigroup increased their price objective on shares of Rentokil Initial from GBX 240 ($3.14) to GBX 350 ($4.57) and gave the stock a neutral rating in a report on Tuesday, July 3rd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of GBX 365.83 ($4.78).
RTO opened at GBX 303.80 ($3.97) on Wednesday. Rentokil Initial has a twelve month low of GBX 238.20 ($3.11) and a twelve month high of GBX 338.80 ($4.43).
Rentokil Initial Company Profile
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.
See Also: What is the Dividend Aristocrat Index?
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.